Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects

To see if variations in timing of rapamycin (Rapa), administered to middle aged mice starting at 20 months, would lead to different survival outcomes, we compared three dosing regimens. Initiation of Rapa at 42 ppm increased survival significantly in both male and female mice. Exposure to Rapa for a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Aging Cell
Hlavní autoři: Strong, Randy, Miller, Richard A., Bogue, Molly, Fernandez, Elizabeth, Javors, Martin A., Libert, Sergiy, Marinez, Paul Anthony, Murphy, Michael P., Musi, Nicolas, Nelson, James F., Petrascheck, Michael, Reifsnyder, Peter, Richardson, Arlan, Salmon, Adam B., Macchiarini, Francesca, Harrison, David E.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7681050/
https://ncbi.nlm.nih.gov/pubmed/33145977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acel.13269
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky